Summit Therapeutics SMMT
NASDAQ SMMT
$17.60 +0.48 (+2.77%)
As of: Sep 4, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) Operating Margin (QoQ) (2017 - 2022)

Analysis

Summit Therapeutics (SMMT) Operating Margin (QoQ) (2017 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Summit Therapeutics 13.67 Bn 12.98 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -229,915.00
Jun 30, 2022 346,235.00
Mar 31, 2022 151,409.00
Dec 31, 2021 -888,867.00
Sep 30, 2021 4.01 Mn
Jun 30, 2021 -3.28 Mn
Mar 31, 2021 -256,758.00
Dec 31, 2020 311,318.00
Sep 30, 2020 -32,673.00
Jun 30, 2020 -615,023.00
Mar 31, 2020 1.59 Mn
Dec 31, 2019 -1.46 Mn
Oct 31, 2019 -239,529.00
Oct 31, 2018 -331,052.00
Jul 31, 2018 55,128.00
Apr 30, 2018 25,535.00
Jan 31, 2018 -23,026.00
Oct 31, 2017 -27,145.00
Jul 31, 2017 48,148.00